Janet Anderson Silvester - Comment

Document ID: FDA-2011-N-0690-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 09 2011, at 12:00 AM Eastern Standard Time
Date Posted: December 21 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: September 29 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: December 23 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f7f009
View Document:  View as format xml

View Comment

I am the Director of Pharmacy at a community hospital. As a result of the drug shortages we have had to consider delaying elective surgery. We have had to delay ECT treatments for psych patients. We have delayed chemotherapy due to a shortage of 5FU. Each time there is a new drug shortage we have to look for alternatives. All too often these alternatives are also unavailable. We are forced to use unfamiliar drugs or concentrations that significantly increase the risk of serious errors. we have to compound doses that were previously available as premix and this dangerously increases our IV room workload and introduces another opportunity for error. We cannot provide our patients with the standard of care that they deserve. We must find a solution to this problem before more patients are harmed. The costs for alternative drugs and for lost productivity are significant and we are often faced with paying rediculous prices in order to provide treatments for pur patients. This must be resolved somehow.

Related Comments

    View All
Total: 83
Janet Anderson Silvester - Comment
Public Submission    Posted: 12/21/2011     ID: FDA-2011-N-0690-0003

Dec 23,2011 11:59 PM ET
Lloyd Wayne Nye - Comment
Public Submission    Posted: 12/21/2011     ID: FDA-2011-N-0690-0004

Dec 23,2011 11:59 PM ET
Michelle Rockey - Comment
Public Submission    Posted: 12/21/2011     ID: FDA-2011-N-0690-0006

Dec 23,2011 11:59 PM ET
Richard Niel Maosn - Comment
Public Submission    Posted: 12/21/2011     ID: FDA-2011-N-0690-0007

Dec 23,2011 11:59 PM ET
Robert Benjamin Zupancich - Comment
Public Submission    Posted: 12/21/2011     ID: FDA-2011-N-0690-0008

Dec 23,2011 11:59 PM ET